| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $37.2M | — | -48.8% |
| Cost of Revenue | $35.0M | — | -45.7% |
| Gross Profit | $2.2M | — | -73.2% |
| R&D Expense | $455K | — | -0.7% |
| SG&A Expense | $1.8M | — | -41.0% |
| Operating Income | -$280K | — | -106.3% |
| Interest Expense | $6K | — | -97.9% |
| Pre-tax Income | -$409K | — | -111.2% |
| Income Tax | $58K | — | -94.3% |
| Net Income | -$467K | — | -117.8% |
| EPS (Basic) | -$0.00 | — | -117.2% |
| EPS (Diluted) | -$0.00 | — | -118.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.8M | +29.9% | -19.1% |
| Accounts Receivable | $195K | -95.2% | -87.2% |
| Current Assets | $19.1M | -20.8% | -20.7% |
| Total Assets | $58.1M | -16.3% | -23.3% |
| Current Liabilities | $25.7M | -23.2% | -6.4% |
| Long-term Debt | $2.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.4M | — | -67.6% |
| Investing Cash Flow | -$18K | — | +96.7% |
| Financing Cash Flow | -$1.7M | — | -8.1% |
| -66.8% |
| Total Liabilities | $43.3M | -20.1% | -16.4% |
| Stockholders' Equity | $14.8M | -3.1% | -38.2% |